Welcome to LIDE PHARMACEUTICALS LTD.
- louis@lidepharma.com
- Language:
Your Location：Home >Production
PRODUCTION & MANUFACTURING
Two manufacturing bases in Shandong and Fujian, with specialized reaction equipment, GMP and non-GMP workshops, and well-established quality and EHS systems.
LIDE provides global innovative pharmaceutical companies with core services spanning small-scale trials, pilot scale-up and commercial production. Our manufacturing network is supported by documented quality management and EHS systems, a strong delivery track record, and reaction capacities that cover the full range from development to commercial supply.
2018 · PENGLAI, SHANDONG
Four production and synthesis workshops equipped with specialized reaction equipment for demanding process conditions.
MARCH 2021 · SHAOWU, FUJIAN
A modern manufacturing base comprising GMP workshops and multiple non-GMP workshops, with reactors from 50 to 5,000 liters to meet diverse production conditions.
Our equipment and systems support a wide range of reaction conditions and production scales, with reliable delivery for customers across the pharmaceutical industry. Products cover major therapeutic areas including:
Since our 2023 strategic transformation, we have built more than 60 mature drug peptide products with annual capacity above one ton and over 20,000 custom peptides delivered. We support customers from R&D scale (mg) and pilot scale through to commercial production (kgs), including peptide APIs and intermediates, cosmetic peptides, protected amino acids and peptide library construction.
